| dbo:abstract |
Cephalon, Inc. era una empresa biofarmacèutica amb seu a a l'estat de Pennsilvània als Estats Units. La companyia era especialitzada en els camps de la neurologia, analgèsica i oncologia. La companyia va ser creada el 1987 pel neuròleg Frank Baldino. El 2010 va adquirir el fabricant suís de genèrica Mepha del grup Merckle. El 2011 tenia uns 3700 empleats. El 2011 la companyia israeliana Teva, especialista en medicaments genèrics al seu torn va adquirir Cephalon. Tenia una filial a Sant Cugat del Vallès. (ca) شركة سيفالون (بالألمانية: Cephalon, Inc.) كانت شركة صيدلانية أمريكية مقرها في ، بنسيلفانيا، استحوذت عليها شركة تيفا في مايو 2011 بصفقة بلغت 6.8 مليار دولار أمريكي. (ar) Cephalon, Inc. war ein US-amerikanisches Pharmaunternehmen. Das 1987 gegründete Unternehmen wurde 2011 vom israelischen Pharmakonzern Teva übernommen. (de) Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases. As noted by fundinguniverse.com, in its early years, "Cephalon initially avoided involving itself in activities that would require maintaining a sales staff, managing clinical trials, and shepherding new drugs through the Food and Drug Administration (FDA) approval process. With no product to sell, Cephalon's only asset was its scientific expertise. That expertise proved sufficient to attract investors, and the company managed to fund its operations through research grants and contracts with larger pharmaceutical firms." Cephalon was first included in the Fortune 1000 list of U.S. companies based upon annual revenues for 2006. Sales revenues reached $2.8 billion in 2010, ranking Cephalon among the leading biopharmaceutical companies in the world at that time. On May 2, 2011, Teva Pharmaceutical Industries announced it would acquire Cephalon. (en) Cephalon est une entreprise américaine filiale de la société israélienne Teva Pharmaceutical Industries. Elle fait partie de l'indice NASDAQ-100 (fr) |
| dbo:foundedBy |
dbr:Frank_Baldino_Jr. |
| dbo:foundingYear |
1987-01-01 (xsd:gYear) |
| dbo:industry |
dbr:Biopharmaceutical dbr:Biotechnology |
| dbo:numberOfEmployees |
3726 (xsd:nonNegativeInteger) |
| dbo:product |
dbr:Provigil dbr:Gabitril dbr:Actiq |
| dbo:type |
dbr:Subsidiary |
| dbo:wikiPageExternalLink |
http://www.cephalon.com https://www.tevapharm.com |
| dbo:wikiPageID |
7925018 (xsd:integer) |
| dbo:wikiPageLength |
14447 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1118939512 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Provigil dbr:Bendamustine dbr:Insulin-like_growth_factor dbr:Gabitril dbr:Nuvigil dbc:Biotechnology_companies_of_the_United_States dbc:Biotechnology_companies_established_in_1987 dbc:Pharmaceutical_companies_established_in_1987 dbr:Salt_Lake_City,_Utah dbr:Chronic_myelogenous_leukemia dbr:Frazer,_Pennsylvania dbr:Gail_Wilensky dbc:1987_establishments_in_Pennsylvania dbr:Modafinil dbc:2011_disestablishments_in_Pennsylvania dbr:Sleep_apnea dbr:Company dbr:Frank_Baldino_Jr. dbc:2011_mergers_and_acquisitions dbc:Health_care_companies_based_in_Pennsylvania dbc:Pharmaceutical_companies_disestablished_in_2011 dbr:West_Chester,_Pennsylvania dbr:Actiq dbr:Amyotrophic_lateral_sclerosis dbc:Defunct_companies_based_in_Pennsylvania dbr:Federal_Trade_Commission dbr:Food_and_Drug_Administration dbc:Companies_formerly_listed_on_the_Nasdaq dbr:Fentora dbr:Subsidiary dbr:Arsenic_trioxide dbc:Defunct_pharmaceutical_companies_of_the_United_States dbr:Chiron_Corporation dbr:Biopharmaceutical dbr:Biotechnology dbr:Philadelphia dbr:IGF-1 dbr:Narcolepsy dbr:Oncology dbc:Biotechnology_companies_disestablished_in_2011 dbr:Shift_work_sleep_disorder dbr:Neurodegenerative_disease dbr:Teva_Pharmaceutical_Industries dbr:Minneapolis,_Minnesota dbr:Omapro dbr:Treanda dbr:Amrix dbr:DuPont_Company dbr:Kinase_inhibitor dbr:Trisenox |
| dbp:founder |
Michael Lewis (en) * Frank Baldino (en) James C. Kauer (en) |
| dbp:homepage |
http://www.cephalon.com |
| dbp:industry |
dbr:Biopharmaceutical dbr:Biotechnology |
| dbp:keyPeople |
J. Kevin Buchi, CEO (en) |
| dbp:name |
Cephalon, Inc. (en) |
| dbp:numEmployees |
0001-12-31 (xsd:gMonthDay) |
| dbp:products |
alertness drug Provigil, the painkiller Actiq, seizure medication Gabitril (en) |
| dbp:type |
Subsidiary of Teva Pharmaceutical Industries (en) |
| dbp:wikiPageUsesTemplate |
dbt:Refimprove_science dbt:Anchor dbt:Better_source dbt:Cn dbt:Div_col dbt:Div_col_end dbt:For dbt:Infobox_company dbt:More_citations_needed dbt:Multiple_issues dbt:No_wrap dbt:Over-quotation dbt:Portal dbt:Refimprove_section dbt:Reflist dbt:Short_description dbt:Small dbt:Start_date_and_age dbt:Unreferenced_section dbt:Update dbt:Update_after dbt:Use_mdy_dates dbt:When dbt:Verification_needed dbt:Philadelphia_Corporations dbt:Cite_quote dbt:Cite_check dbt:Citation_needed_lead dbt:Pharmaceutical_companies_of_the_United_States |
| dbp:wordnet_type |
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 |
| dcterms:subject |
dbc:Biotechnology_companies_of_the_United_States dbc:Biotechnology_companies_established_in_1987 dbc:Pharmaceutical_companies_established_in_1987 dbc:1987_establishments_in_Pennsylvania dbc:2011_disestablishments_in_Pennsylvania dbc:2011_mergers_and_acquisitions dbc:Health_care_companies_based_in_Pennsylvania dbc:Pharmaceutical_companies_disestablished_in_2011 dbc:Defunct_companies_based_in_Pennsylvania dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Defunct_pharmaceutical_companies_of_the_United_States dbc:Biotechnology_companies_disestablished_in_2011 |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesEstablishedIn1987 yago:WikicatCompaniesInTheNASDAQ-100Index yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates umbel-rc:Business |
| rdfs:comment |
Cephalon, Inc. era una empresa biofarmacèutica amb seu a a l'estat de Pennsilvània als Estats Units. La companyia era especialitzada en els camps de la neurologia, analgèsica i oncologia. La companyia va ser creada el 1987 pel neuròleg Frank Baldino. El 2010 va adquirir el fabricant suís de genèrica Mepha del grup Merckle. El 2011 tenia uns 3700 empleats. El 2011 la companyia israeliana Teva, especialista en medicaments genèrics al seu torn va adquirir Cephalon. Tenia una filial a Sant Cugat del Vallès. (ca) شركة سيفالون (بالألمانية: Cephalon, Inc.) كانت شركة صيدلانية أمريكية مقرها في ، بنسيلفانيا، استحوذت عليها شركة تيفا في مايو 2011 بصفقة بلغت 6.8 مليار دولار أمريكي. (ar) Cephalon, Inc. war ein US-amerikanisches Pharmaunternehmen. Das 1987 gegründete Unternehmen wurde 2011 vom israelischen Pharmakonzern Teva übernommen. (de) Cephalon est une entreprise américaine filiale de la société israélienne Teva Pharmaceutical Industries. Elle fait partie de l'indice NASDAQ-100 (fr) Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases. As noted by fundinguniverse.com, in its early years, (en) |
| rdfs:label |
سيفالون (ar) Cephalon, Inc. (ca) Cephalon (Unternehmen) (de) Cephalon (en) Cephalon (fr) |
| owl:sameAs |
freebase:Cephalon http://sw.cyc.com/concept/Mx4rve-8T5wpEbGdrcN5Y29ycA yago-res:Cephalon wikidata:Cephalon dbpedia-ar:Cephalon dbpedia-ca:Cephalon dbpedia-de:Cephalon dbpedia-fa:Cephalon dbpedia-fr:Cephalon https://global.dbpedia.org/id/Xk9e |
| prov:wasDerivedFrom |
wikipedia-en:Cephalon?oldid=1118939512&ns=0 |
| foaf:homepage |
http://www.cephalon.com |
| foaf:isPrimaryTopicOf |
wikipedia-en:Cephalon |
| foaf:name |
Cephalon, Inc. (en) |
| is dbo:wikiPageDisambiguates of |
dbr:Ceph |
| is dbo:wikiPageRedirects of |
dbr:Mepha dbr:CEPH_(NASDAQ) dbr:Cephalon,_Inc. dbr:Cephalon_Inc dbr:Cephalon_Inc. |
| is dbo:wikiPageWikiLink of |
dbr:Mesoblast dbr:Bausch_Health dbr:Bendamustine dbr:Paul_H._Nitze_School_of_Advanced_International_Studies dbr:Reslizumab dbr:David_Fox_(lawyer) dbr:Deaths_in_December_2010 dbr:List_of_people_from_Philadelphia dbr:List_of_largest_civil_only_pharmaceutical_settlements dbr:List_of_largest_pharmaceutical_settlements dbr:List_of_off-label_promotion_pharmaceutical_settlements dbr:List_of_pharmaceutical_companies dbr:List_of_pharmaceutical_manufacturers_in_the_United_Kingdom dbr:Chronic_myelogenous_leukemia dbr:Modafinil dbr:Lestaurtinib dbr:Frank_Baldino_Jr. dbr:Tiagabine dbr:John_E._Osborn_(lawyer) dbr:List_of_College_of_William_&_Mary_alumni dbr:Adrafinil dbr:Fluorenol dbr:List_of_Muhlenberg_College_people dbr:List_of_S&P_500_companies dbr:Teva_Pharmaceuticals dbr:William_P._Egan dbr:Armodafinil dbr:Cheloniellida dbr:Jerry_Pappert dbr:Jean_Deleage dbr:Redlichia_chinensis dbr:Burr,_Egan,_Deleage_&_Co. dbr:Mepha dbr:Krill dbr:Nasdaq-100 dbr:Obatoclax dbr:CEPH_(NASDAQ) dbr:Ceph dbr:Off-label_use dbr:List_of_companies_of_the_United_States_by_state dbr:List_of_drugs:_Ac dbr:Cephalon,_Inc. dbr:Cephalon_Inc dbr:Cephalon_Inc. |
| is foaf:primaryTopic of |
wikipedia-en:Cephalon |
